GlassScriptPhysician profile
Daniel L Wagstaff
NPI 1417904442
$452.45
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $69.61 · 2021: $107 · 2022: $15.15 · 2023: $43.75 · 2024: $24.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $67.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $67.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $105.67 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $63.07 | 2019-2020 | |
| Pfizer INC. | $60.41 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $50.41 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.45 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $26.08 | 2020-2021 | |
| Vifor Pharma, INC. | $19.04 | 2019 | |
| Medtronic Vascular, INC. | $15.46 | 2019 | |
| Amarin Pharma, INC. | $15.27 | 2021 | |
| Abbvie INC. | $15.15 | 2022 | |
| Philips North America LLC | $14.91 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $13.83 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.40 | 2021 | |
| Melinta Therapeutics, LLC | $11.30 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wagstaff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.